Presented by: Melissa Badowski,
Clinical Associate Professor,
University of Illinois at Chicago College of Pharmacy
An estimated 36.7 million people worldwide live with HIV — with 19.5 million people receiving antiretroviral treatment (ART). As specialty pharmacies consider taking on more patients impacted by this disease state, it is crucial to understand the latest developments, treatment options, and future outlook.
Join us for a free webinar presented by Melissa Badowski, PharmD, BCPS, AAVHIVP, MPH clinical associate professor at the University of Illinois at Chicago College of Pharmacy. In this presentation, Melissa will discuss newly approved HIV therapies — both brand name and generic — and how these new options contribute to continued innovation in HIV/AIDS therapy.
Attend to learn about:
- Data on 2-drug regimens (2DR)
- Identifying appropriate candidates for ibalizumab therapy
- Providing patient counseling on antiretroviral agents, including: Juluca, Biktarvy, Cimduo, Symfi, Symfi Lo, and Trogarzo
Presenter: Melissa Badowski, PharmD, BCPS, AAVHIVP, MPH,
Clinical Associate Professor, University of Illinois at Chicago College of Pharmacy
Fill out the form to watch the video.
This column can be used for anything!